Clinician's Manual Treatment of Hypertension

Fourth Edition
1. Auflage 2024
ISBN: 978-3-319-18187-5
Verlag: Springer-Verlag GmbH

Buch, Englisch, 96 Seiten, Book, Format (B × H): 155 mm x 235 mm

Reihe: Advances in Information Security

This comprehensive pocketbook provides a foundation in best-practice guidance screening, assessing, treating, and monitoring patients with hypertension, with reference to up-to-date clinical guidelines. Prevention strategies and recent drug developments are also highlighted, including the most exciting and relevant treatment advances in the past 5 years. Hypertension is one of the most common medical conditions, with an estimated one billion people worldwide affected. Because hypertension affects so many and spans across all ages, ethnicities, and socioeconomic classes, nearly all clinicians encounter patients with hypertension on regular basis. The Clinician's Manual: Treating Hypertension, 4th edition provides a foundation in best-practice guidance screening, assessing, treating, and monitoring patients with hypertension, with reference to up-to-date clinical guidelines. Prevention strategies and recent drug developments are also highlighted, including the most exciting and relevant treatment advances in the past 5 years.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Messerli, Franz H.

Rimoldi, Stefano

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Evidenzbasierte Medizin (EbM)

Inhaltsverzeichnis

Definition of hypertension.- The J curve.- Drug therapy or lifestyle modification?.- First-line antihypertensive therapy: the simplistic viewpoint.- Hypertension as a gateway to cardiovascular risk modification.- To twofer or not to twofer.- When initial therapy is insufficient – To up titrate, to substitute, or to combine?.- How aggressively should blood pressure be lowered?.- Evidence-based versus eminence-based therapy.- Combination therapy.- Comorbid conditions.- Therapeutic challenges.- Fashions and fads.

Über Autor(innen)

Franz H Messerli, MD, FACC, FACP, is Director of the Hypertension Program, Division of Cardiology at St Luke's-Roosevelt Hospital and Professor of Clinical Medicine at Columbia University, College of Physicians and Surgeons in New York City, NY, USA. Dr Messerli is the author and co-author of more than 700 publications and book chapters. He has served on the Cardiorenal Advisory Committee of the US Food & Drug Administration (FDA) and Joint National Committee. He is a member of several editorial boards, and has received various awards and degrees for his scientific activity. He is also a Founding Member of the American Society of Hypertension; an Honorary Member of the Southern African Hypertension Society; and an Honorary Fellow or Member of the Philippine College of Physicians, the Brazilian Society of Cardiology, the Bulgarian Society of Cardiology, the Peruvian Society of Cardiology, and the Columbian Society of Cardiology.